XTAI
4164
Market cap171mUSD
Oct 08, Last price
28.00TWD
1D
-0.71%
1Q
-3.45%
Jan 2017
-36.07%
IPO
-80.38%
Name
CHC Healthcare Group
Chart & performance
P/E
29.36
P/S
1.24
EPS
0.95
Div yield, %
4.85%
Shrs. gr., 5y
2.32%
Rev. gr., 5y
11.48%
Revenues
4.40b
+22.15%
Net income
186m
+10.63%
CFO
1.03b
+934.64%
Dividend
Jun 29, 20261.10774 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Taipei, Taiwan, in 1977, the CHC Healthcare Group delivers a wide array of healthcare management services both within Taiwan and globally. Its core activities involve the distribution, installation, maintenance, and leasing of medical equipment. Furthermore, the company extends its expertise to include business management consulting, educational programs, elder care provisions, and radiation sterilization operations. The specialized equipment it provides serves key medical fields such as radiation oncology, neurology, medical imaging, ophthalmology, and surgery.
Key people
Vice Chairman of the Board, Chief Human Resources Officer · since 2025
Yi-Chun Chen
Chief Financial Officer, Corporate Governance Officer · since 2021
Ming-Lun Lee
General Manager · since 2023
Director · since 2010
Chun-Shung Huang
Director · since 2012
Chairman of the Board, Chief Investment Officer · since 2025
Chih Chi
Independent Director · since 2023
Ming-Liang Kao
Independent Director · since 2023
Geng-Wang Liaw
Independent Director · since 2017
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||